Male Breast Cancer

We have extensive experience in diagnosing and managing male breast cancer, a rare condition. Our imaging specialists and pathologists, as well as surgical, radiation, and medical oncologists, collaborate to create an individualized treatment plan for you based on the type of breast cancer, the molecular features of the tumor tissue, and how advanced the cancer is. Our doctors are active in clinical trials for men with breast cancer, and you and your doctor can discuss whether enrolling in one is right for you.

Clinical Trials and Research Studies

Phase 3

SAR439859 plus palbociclib as first line therapy for patients with ER (+) HER2(-) advanced breast cancer (AMEERA-5)

Learn More

Phase 3

A Randomized Double-Blind Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Learn More

Phase -1

The Safety and Effectiveness of DuraSorb for Lower Pole Reinforcement in Patients Undergoing 2 Stage Breast Reconstruction

Learn More

Phase 5

A randomized Phase I/II trial of fulvestrant and abemaciclib in combination with copanlisib (FAC) versus fulvestrant and abemaciclib alone (FA) for endocrine-resistant hormone receptor positive HER2 negative metastatic breast cancer (FAC vs FA)

Learn More